Int'l : +1(646) 600-5072 | query@kbvresearch.com
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Skin Antiseptic Market size is expected to reach $2.5 billion by 2029, rising at a market growth of 7.4% CAGR during the forecast period.
The Alcohol segment is leading the Global Skin Antiseptic Segment by Type in 2022 thereby, achieving a market value of $970.2 million by 2029. This is due to pre-injection or pre-operative skin preparation usage rising. In addition, the segment is expanding due to the rising demand for alcohol bases that can be combined with other ingredients like iodine and chlorhexidine. Furthermore, antiseptic ingredients like isopropyl or ethyl, which are powerful against various microorganisms, are included in alcohol skin antiseptic products.
The Hospital Pharmacies segment is showcasing a CAGR of 7.6% during (2023 - 2029). Due to a rise in patients with hospital-acquired infections, hospitals are being visited more frequently for specialized medical care, raising the need for skin antiseptics in hospital pharmacies. In addition, the market is expanding due to patients' growing interest in maintaining a sanitary lifestyle.
The Solution segment acquired maximum revenue share in the Global Skin Antiseptic Market by Form in 2022 thereby, achieving a market value of $1.1 billion by 2029. This might be attributed to the high prevalence of SSIs and HAIs in hospitals and the simple accessibility of a wide range of products on the market. Moreover, the market is driven by rising awareness and expanding uses of antiseptic solutions in skin preparation before operations and injections. As a result, the risk of contamination and disease transmission is drastically decreased by antiseptic solutions.
The North America market is generating the highest revenue share in the Global Skin Antiseptic Market by Region in 2022 thereby, achieving a market value of $828.8 million by 2029. The Europe market is poised to grow at a CAGR of 6.8% during (2023 - 2029). Additionally, The Asia Pacific market would showcase a CAGR of 8.3% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/skin-antiseptic-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of XTTRIUM Laboratories, Sirmaxo Chemicals Private Limited, SCHÜLKE & Mayr GmbH, MÖLNLYCKE Health Care (Investor AB), Cardinal Health, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, 3M Company, PDI Healthcare, Inc. and Ecolab, Inc.
By Type
By Distribution Channel
By Form
By Geography
Companies Profiled
Related Reports: